Evidence-based psychopharmacology
Author(s)
Bibliographic Information
Evidence-based psychopharmacology
Cambridge University Press, 2005
- : hbk
- : pbk
Available at 11 libraries
  Aomori
  Iwate
  Miyagi
  Akita
  Yamagata
  Fukushima
  Ibaraki
  Tochigi
  Gunma
  Saitama
  Chiba
  Tokyo
  Kanagawa
  Niigata
  Toyama
  Ishikawa
  Fukui
  Yamanashi
  Nagano
  Gifu
  Shizuoka
  Aichi
  Mie
  Shiga
  Kyoto
  Osaka
  Hyogo
  Nara
  Wakayama
  Tottori
  Shimane
  Okayama
  Hiroshima
  Yamaguchi
  Tokushima
  Kagawa
  Ehime
  Kochi
  Fukuoka
  Saga
  Nagasaki
  Kumamoto
  Oita
  Miyazaki
  Kagoshima
  Okinawa
  Korea
  China
  Thailand
  United Kingdom
  Germany
  Switzerland
  France
  Belgium
  Netherlands
  Sweden
  Norway
  United States of America
Note
Includes bibliographical references and index
Description and Table of Contents
Description
This book presents a comprehensive overview of recent advances in evidence-based pharmacological treatment of psychiatric disorders. There have been very significant developments in our understanding of the methods for systematically reviewing literature, assessing clinical trials and optimising decision making. The book explores these issues and applies the lessons learned to the practical management of major psychiatric conditions, addressing issues such as selecting the best first-line psychopharmacological intervention for a particular disorder, how long a particular intervention should be continued, and identifying the next-best treatment strategy should the first agent fail. Conditions covered include, amongst others, depression, schizophrenia, panic, PTSD, OCD, ADHD and eating disorders. The potential for complications as a result of adverse interactions between drugs is also examined. These issues lie at the heart of clinical psychopharmacology and the book will therefore appeal to all practising clinicians, whether in a primary care or a specialist mental health setting.
Table of Contents
- 1. Evidence-based pharmacotherapy of major depressive disorder Michael Ostacher, Jeffrey Huffman, Roy Perlis and Andrew A. Nierenberg
- 2. Evidence-based pharmacotherapy of bipolar disorder S. Nassir Ghaemi and Douglas J. Hsu
- 3. Evidence-based pharmacotherapy of schizophrenia Robin Emsley and Piet Oosthuizen
- 4. Evidence-based pharmacotherapy of generalised anxiety disorder David S. Baldwin and Claire Polkinghorn
- 5. Evidence-based pharmacotherapy of panic disorder Abraham Bakker, Anton J. L. M. van Balkom and Dan J. Stein
- 6. Evidence-based pharmacotherapy of post-traumatic stress disorder C. Barbara Portier, Abraham Bakker, Anton J. L. M. van Balkom and Dan J. Stein
- 7. Evidence-based pharmacotherapy of social anxiety disorder Carlos Blanco, Muhammad S. Raza, Franklin R. Schneier and Michael R. Liebowitz
- 8. Evidence-based pharmacotherapy of obsessive-compulsive disorder Naomi A. Fineberg and Tim M. Gale
- 9. Evidence-based pharmacotherapy of eating disorders Martine F. Flament, Claudia Furino and Nathalie Godart
- 10. Evidence-based pharmacotherapy of attention deficit hyperactivity disorder Joseph Biederman, Thomas Spencer and Timothy Wilens
- 11. Evidence-based pharmacotherapy of Alzheimer's Disease John G. Evans, Gordon Wilcock and Jacqueline Birks
- 12. Drug interactions C. Lindsay DeVane.
by "Nielsen BookData"